Course Listing
Advance your knowledge in engaging, interactive courses developed and taught by leaders in the field.
Browse All MDS Courses
New courses are added regularly. If there are not courses listed in the category you are searching, more will be scheduled at a later date. Check back soon or sign up for email notifications.
Please wait while we gather your results.
Journal CME 40.10: Protective Effects of Genetic Proxies of Cognitive Reserve in Parkinson’s Disease: A Longitudinal Multi-Cohort Study
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.001046 <p>The Journal CME 40.10 article aims to evaluate the utility of polygenic scores (PGSs) for cognitive reserve proxies, including intelligence (INT), educational attainment (EA), and occupational attainment (OA), in predicting the clinical progression of PD.</p> Anxiety/Depression, Autonomic Dysfunction, Cognitive impairment/Dementia, Etiology & Pathophysiology, Genetics, Impulse Control Disorders, Neuropsychiatric symptoms, Non-motor Symptoms/Disorders, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Psychosis, Sensory disorders, Sleep Disorders, Speech Disorders Young Eun Huh, MD, PhD 60 1.00 https://education.movementdisorders.org/Detail/1046/Journal-CME-40-10:-Protective-Effects-of-Genetic-Proxies-of-Cognitive-Reserve-in-Parkinson’s-Disease:-A-Longitudinal-Multi-Cohort-Study https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2025-10-06T00:00:00 2026-10-06T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.10%20-%20Disclosures_01102025093927.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the role of cognitive reserve and its genetic proxies in influencing the progression of Parkinson’s disease</p><p>2. Assess the predictive value of polygenic scores for intelligence, educational attainment, and occupational attainment in clinical outcomes of PD</p><p>3. Evaluate how genetic markers of cognitive reserve can inform prognosis and contribute to personalized management strategies in PD</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-40.10-Protective-Effects-of-Genetic-Proxies-of-Cognitive-Reserve-in-Parkinsons-Disease-A-Longitudinal-Multi-Cohort-Study.htm Journal CME 40.10: Protective Effects of Genetic Proxies of Cognitive Reserve in Parkinson’s Disease: A Longitudinal Multi-Cohort Study Journal CME 40.10 2025-10-06T18:01:04.397 0 0 Experienced / Intermediate Clinician Fellow Industry Researcher Resident Journal CME CME English On-Demand USA
336299.png)
Focused Workshop Parkinson’s Disease Decoded: Genes, Environment, and the Epidemiological Challenge
In-Person
Lübeck, Germany
May 08, 2026 - May 10, 2026
996 <p><strong>Parkinson’s Disease Decoded: Genes, Environment, and the Epidemiological Challenge</strong> program brings together leading experts in the field to explore the complex interplay of genetics, environmental exposures, and emerging epidemiological trends in Parkinson’s disease (PD). Through a mix of plenary lectures, interactive panel discussions, and abstract presentations, participants will gain critical insights into the biological, molecular, and clinical dimensions of PD, as well as the translational challenges in diagnosis, treatment, and prevention. <br /></p> 1200 0.00 https://education.movementdisorders.org/Detail/996/MDS-ES-Focused-Workshop-Parkinson’s-Disease-Decoded:-Genes,-Environment,-and-the-Epidemiological-Challenge https://education.movementdisorders.org/Upload/ActivityImages/image-(2)336299.png 2026-05-08T00:00:00 2026-05-10T00:00:00 Lübeck MDS Education <p><!--[if !vml]--><!--[endif]--><strong><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/2026_ES%20FW-PD%20Decoded_Agenda%20(Post%2010.1.25)_30092025103523.pdf" rel="noopener noreferrer" target="_blank"><img src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1758823072889_25092025125751.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a></strong><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/2026_ES%20FW-PD%20Decoded_Agenda%20(Post%2010.1.25)_30092025103523.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Schedule </strong></a><!--[if !vml]--><!--[endif]--><strong><a href="https://form.jotform.com/252656355394163" rel="noopener noreferrer" target="_blank"><img src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1758823100266_25092025125819.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a></strong><a href="https://form.jotform.com/252656355394163" rel="noopener noreferrer" target="_blank"><strong>Travel Bursary </strong><!--[if !vml]--><!--[endif]--><strong> </strong></a><strong><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty%20Listing_30092025103600.pdf" rel="noopener noreferrer" target="_blank"><img src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1758823118287_25092025125837.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a></strong><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty%20Listing_30092025103600.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Faculty</strong></a></p><p><br></p><p><em>Schedule as of October 1, 2025 </em></p><p><em><strong>Travel Bursary Deadline:</strong></em><em><strong> </strong></em><em>December 31</em><em>, 2025</em><br><a href="https://form.jotform.com/252656076502154" rel="noopener noreferrer" target="_blank"><em><em><strong>Abstract Submission</strong></em></em></a><em><em><strong> Deadline:</strong></em><em><strong> </strong></em><em>December 31</em><em>, 2025</em></em></p><p><br></p><p><strong>REGISTRATION FEES</strong><br><strong>Members:</strong> $300 USD<br><strong>Members: Junior / HP / Basic Science / No Fee:</strong> $225 USD<br><strong>Non-Members*:</strong> $400 USD</p><p>*<em>Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of the close of registration.</em></p><p><a href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/VISA%20STATEMENT%20CANCELLATION%20LANGUAGE_24012024041714.pdf">Click here to view the MDS Regional Course Cancellation Policy & Visa Assistance Information</a></p><p><br></p><p><strong>COURSE VENUE</strong></p><p>Audimax Lübeck,<br>University Hospital Schleswig-Holstein,<br>Lübeck, Germany</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. <strong>Evaluate the current epidemiological trends</strong> in Parkinson’s disease, including the potential global rise in incidence and the multifactorial contributors to its prevalence.<br>2. <strong>Analyze the major genetic contributors to PD</strong>, including the role of monogenic mutations and genetic risk factors (e.g., LRRK2, GBA), the known modifiers of penetrance and the influence of gene-environment interactions.<br>3. <strong>Discuss the significance of genome-wide association studies (GWAS)</strong>, epigenetic mechanisms, and transcriptomic data in advancing precision medicine approaches for PD.<br>4. <strong>Understand the pathogenic role of α-synuclein</strong>, including its interactions with mitochondrial damage, protein clearance systems, and its relevance to glial and neuronal dysfunction.<br>5. <strong>Explore the gut-brain axis and microbiota-based therapies</strong> as emerging fields in PD pathogenesis and intervention strategies.<br>6.<strong> Investigate the roles of neuroinflammation and immune response</strong>, with a focus on lipid metabolism and targeted therapeutic opportunities.<br>7. <strong>Critically appraise the use of artificial intelligence</strong> in stratifying disease trajectories and improving personalized care models for Parkinson’s disease.</p> <p>The organizers invite interested participants to submit an abstract for poster presentation during the 2026 ES Focused Workshop. Poster Presentation will occur on day 2 of the workshop, Saturday, May 9, 2026.<br><br>Abstracts should be submitted on topics that are in line with the 2026 ES Focused Workshop Program.</p><p><br></p><p><strong>ABSTRACT SUBMISSION</strong>: <a href="https://form.jotform.com/252656076502154" rel="noopener noreferrer" target="_blank">https://form.jotform.com/252656076502154</a></p><p><strong><em>Abstract Submission</em></strong><em><strong> Deadline:</strong></em><em><strong> </strong></em>December 31<em>, 2025</em></p> Lübeck 0 /Courses/Focused-Workshop-Parkinsons-Disease-Decoded-Genes-Environment-and-the-Epidemiological-Challenge.htm Focused Workshop Parkinson’s Disease Decoded: Genes, Environment, and the Epidemiological Challenge 2025-09-30T18:00:56.660 0 0 In-Person Germany
Journal CME 40.09: Hematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor-1 Receptor (CSF1R)-Related Disorder
On Demand
Journal CME
60 Minutes
Foundational / Beginner
CME Credits:1.001044 <p>The Journal CME 40.09 article reports multicenter clinical (Expanded Disability Scoring Scale [EDSS]), neurocognitive), neuroimaging (Sundal score), and biological (neurofilament light chain [NfL]) outcomes after HSCT in CSF1R-RD.</p> Genetic & Hereditary Disorders, Infusion therapy, Other Movement Disorders, Therapies-Surgical Hemmo A.F. Yska, MD 60 1.00 https://education.movementdisorders.org/Detail/1044/Journal-CME-40-09:-Hematopoietic-Stem-Cell-Transplantation-in-an-International-Cohort-of-Colony-Stimulating-Factor-1-Receptor-(CSF1R)-Related-Disorder https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2025-09-24T00:00:00 2026-09-24T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.09%20-%20Disclosures_16092025021345.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the clinical rationale and early outcomes of HSCT in CSF1R-RD patients</p><p>2. Assess the significance of neuroimaging and biomarker changes post-HSCT</p><p>3. Evaluate the potential benefits and limitations of reduced-intensity conditioning in CSF1R-RD treatment</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-40.09-Hematopoietic-Stem-Cell-Transplantation-in-an-International-Cohort-of-Colony-Stimulating-Factor-1-Receptor-CSF1R-Related-Disorder.htm Journal CME 40.09: Hematopoietic Stem Cell Transplantation in an International Cohort of Colony Stimulating Factor-1 Receptor (CSF1R)-Related Disorder Journal CME 40.09 2025-09-24T09:01:10.523 0 0 Foundational / Beginner Clinician Fellow Industry Researcher Resident Student Journal CME CME English On-Demand USA
Journal CME 40.08:Cholinergic System Changes in Dopa-Unresponsive Freezing of Gait in Parkinson’s Disease
On Demand
Journal CME
60 Minutes
Foundational / Beginner
CME Credits:1.001029 <p>The Journal CME 40.08 article aims to investigate whether specific cholinergic system changes are associated with FoG responsiveness to levodopa treatment in PD patients.</p> Basic/Translational Neuroscience, Dopaminergic medications, Etiology & Pathophysiology, Medications for motor complications, Medications for motor symptoms, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Therapies-Pharmacological Kelvin L. Chou, MD 60 1.00 https://education.movementdisorders.org/Detail/1029/Journal-CME-40-08:Cholinergic-System-Changes-in-Dopa-Unresponsive-Freezing-of-Gait-in-Parkinson’s-Disease https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2025-09-24T00:00:00 2026-09-24T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.08%20-%20Disclosure%20Template_22082025020404.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the role of cholinergic system degeneration in the development and progression of freezing of gait (FoG) in PD</p><p>2. Evaluate the differences in brain cholinergic activity between patients with levodopa-responsive and levodopa-unresponsive FoG based on VAChT PET imaging findings</p><p>3. Assess how extra-striatal cholinergic deficits may contribute to resistance to levodopa treatment in FoG</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-40.08Cholinergic-System-Changes-in-Dopa-Unresponsive-Freezing-of-Gait-in-Parkinsons-Disease.htm Journal CME 40.08:Cholinergic System Changes in Dopa-Unresponsive Freezing of Gait in Parkinson’s Disease Journal CME 40.08 2025-09-24T09:01:02.210 0 0 Foundational / Beginner Clinician Fellow Industry Researcher Resident Student Journal CME CME English On-Demand USA
Essentials of Device-Assisted Therapies in Parkinson's Disease: Programming a patient with DBS - Conventional STN and GPI, Neurophysiology guided, and Imaging guided programming
On Demand
Device Aided Medical Therapies
30 Minutes
Foundational / Beginner
CME Credits:0.501038 <p>This module will cover programming a patient with DBS from fundamental principles to patient-specific considerations and safety precautions, troubleshooting strategies and optimizing therapeutic outcomes. </p> Deep brain stimulation, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Therapies-Surgical Drew Kern, MD, MS 30 0.50 https://education.movementdisorders.org/Detail/1038/Essentials-of-Device-Assisted-Therapies-in-Parkinson's-Disease:-Programming-a-patient-with-DBS---Conventional-STN-and-GPI,-Neurophysiology-guided,-and-Imaging-guided-programming-- https://education.movementdisorders.org/Upload/ActivityImages/10766771.jpg 2025-09-18T00:00:00 2028-09-18T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 0.5 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/DAT%20Module%2010%20-%20Disclosures_12092025033214.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p><p><br></p> MDS Education <p><strong>FACULTY</strong></p><p>Drew Kern, MD, MS - University of Colorado, Aurora, Colorado, USA</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity learners will be able to:</p><p>1. Demonstrate the adjustment of stimulation parameters. </p><p>2. Identify and minimize common adverse effects by optimizing the parameters. </p><p>3. Implement troubleshooting strategies to address suboptimal therapeutic outcomes. </p><p>4. Use of neurophysiology-based and image guided programming in DBS.</p><p><br></p><p><strong>ABOUT THE ESSENTIALS OF DEVICE ASSISTED THERAPIES SERIES</strong></p><p>The MDS Essentials of Device-Assisted Therapies in Parkinson's Disease Series is an online education program designed to focus on the main practical issues involved in therapeutic treatments of Parkinson's Disease.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This course is intended for students, residents, neurologists, neurosurgeons, specialist nurses, and other health professionals.</p><p><br></p><p><strong>HOW TO TRANSLATE THIS MODULE</strong></p><p>For step-by-step guidance on how to translate this module using the Google Chrome web browser, please watch the video below:</p><p><br></p><p><span class="fr-video fr-dvb fr-draggable" contenteditable="false" draggable="false"> <video class="fr-draggable fr-fvc fr-dvi" controls="" height="300" width="533"><source src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/How To Translate - DAMT_15092025053301.mp4" type="video/mp4"> Your browser does not support HTML5 video.</video> </span></p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher)</p><p>3. Activity is best viewed on Mozilla Firefox or Google Chrome.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Essentials-of-Device-Assisted-Therapies-in-Parkinsons-Disease-Programming-a-patient-with-DBS---Conventional-STN-and-GPI-Neurophysiology-guided-and-Imaging-guided-programming.htm Essentials of Device-Assisted Therapies in Parkinson's Disease: Programming a patient with DBS - Conventional STN and GPI, Neurophysiology guided, and Imaging guided programming 2025-09-18T12:01:08.647 0 0 Foundational / Beginner Clinician Fellow Industry Resident Student Device Aided Medical Therapies CME English On-Demand USA
Essentials of Device-Assisted Therapies in Parkinson's Disease: Deep Brain Stimulation: Selecting patients for DBS
On Demand
Device Aided Medical Therapies
30 Minutes
Foundational / Beginner
CME Credits:0.501037 <p>This module will cover evaluating patients for DBS, anatomical targets, and different available programming options. </p> Deep brain stimulation, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Therapies-Surgical Renato Munhoz, MD 30 0.50 https://education.movementdisorders.org/Detail/1037/Essentials-of-Device-Assisted-Therapies-in-Parkinson's-Disease:-Deep-Brain-Stimulation:-Selecting-patients-for-DBS-- https://education.movementdisorders.org/Upload/ActivityImages/9364355.jpg 2025-09-18T00:00:00 2028-09-18T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 0.5 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/DAT%20Module%209%20-%20Disclosures_12092025034356.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>FACULTY</strong></p><p>Renato Munhoz, MD - University of Toronto, Toronto, ON, Canada</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity learners will be able to:</p><p>1. Understand the clinical indications and patient selection criteria for DBS, different targets, different available options for programming. </p><p>2. How to perform l dopa response test, LED calculation, perioperative drug management.</p><p><br></p><p><strong>ABOUT THE ESSENTIALS OF DEVICE ASSISTED THERAPIES SERIES</strong></p><p>The MDS Essentials of Device-Assisted Therapies in Parkinson's Disease Series is an online education program designed to focus on the main practical issues involved in therapeutic treatments of Parkinson's Disease.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This course is intended for students, residents, neurologists, neurosurgeons, specialist nurses, and other health professionals.</p><p><br></p><p><strong>HOW TO TRANSLATE THIS MODULE</strong></p><p>For step-by-step guidance on how to translate this module using the Google Chrome web browser, please watch the video below:</p><p><br></p><p><span class="fr-video fr-dvb fr-draggable" contenteditable="false" draggable="false"> <video class="fr-draggable fr-fvc fr-dvi" controls="" height="300" width="533"><source src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/How To Translate - DAMT_15092025053301.mp4" type="video/mp4"> Your browser does not support HTML5 video.</video> </span></p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher)</p><p>3. Activity is best viewed on Mozilla Firefox or Google Chrome.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Essentials-of-Device-Assisted-Therapies-in-Parkinsons-Disease-Deep-Brain-Stimulation-Selecting-patients-for-DBS.htm Essentials of Device-Assisted Therapies in Parkinson's Disease: Deep Brain Stimulation: Selecting patients for DBS 2025-09-18T12:01:07.753 0 0 Foundational / Beginner Clinician Fellow Industry Resident Student Device Aided Medical Therapies CME English On-Demand USA
Essentials of Device-Assisted Therapies in Parkinson's Disease: Starting and Managing a patient on Levodopa/Carbidopa Intestinal Gel and Levodopa/Carbidopa/Entacapone Intestinal Gel
On Demand
Device Aided Medical Therapies
30 Minutes
Foundational / Beginner
CME Credits:0.501036 This module will facilitate understanding of the clinical indications and patient selection criteria for initiating LCIG and LCEIG therapies. <br /> Infusion therapy, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Therapies-Pharmacological Maja Trost, MD 30 0.50 https://education.movementdisorders.org/Detail/1036/Essentials-of-Device-Assisted-Therapies-in-Parkinson's-Disease:-Starting-and-Managing-a-patient-on-Levodopa/Carbidopa-Intestinal-Gel-and-Levodopa/Carbidopa/Entacapone-Intestinal-Gel-- https://education.movementdisorders.org/Upload/ActivityImages/8939085.jpg 2025-09-18T00:00:00 2028-09-18T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 0.50 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/DAT%20Module%208%20-%20Disclosures_12092025034246.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>FACULTY</strong></p><p>Maja Trost, MD - University Medical Center Ljubljana, Ljubljana, Slovenia</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity learners will be able to:</p><p>1. Apply appropriate dosing and titration protocols, including test dosing procedures. </p><p>2. Prevent, recognize and manage common adverse effects associated with intestinal infusion therapies to ensure patient safety and treatment adherence.</p><p><br></p><p><strong>ABOUT THE ESSENTIALS OF DEVICE ASSISTED THERAPIES SERIES</strong></p><p>The MDS Essentials of Device-Assisted Therapies in Parkinson's Disease Series is an online education program designed to focus on the main practical issues involved in therapeutic treatments of Parkinson's Disease.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This course is intended for students, residents, neurologists, neurosurgeons, specialist nurses, and other health professionals.</p><p><br></p><p><strong>HOW TO TRANSLATE THIS MODULE</strong></p><p>For step-by-step guidance on how to translate this module using the Google Chrome web browser, please watch the video below:</p><p><br></p><p><span class="fr-video fr-dvb fr-draggable" contenteditable="false" draggable="false"> <video class="fr-draggable fr-fvc fr-dvi" controls="" height="300" width="533"><source src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/How To Translate - DAMT_15092025053301.mp4" type="video/mp4"> Your browser does not support HTML5 video.</video> </span></p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher)</p><p>3. Activity is best viewed on Mozilla Firefox or Google Chrome.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Essentials-of-Device-Assisted-Therapies-in-Parkinsons-Disease-Starting-and-Managing-a-patient-on-LevodopaCarbidopa-Intestinal-Gel-and-LevodopaCarbidopaEntacapone-Intestinal-Gel.htm Essentials of Device-Assisted Therapies in Parkinson's Disease: Starting and Managing a patient on Levodopa/Carbidopa Intestinal Gel and Levodopa/Carbidopa/Entacapone Intestinal Gel 2025-09-18T12:01:06.600 0 0 Foundational / Beginner Clinician Fellow Industry Resident Student Device Aided Medical Therapies CME English On-Demand USA
Essentials of Device-Assisted Therapies in Parkinson's Disease: Starting and managing a patient on Subcutaneous Foslevodopa/Foscarbidopa
On Demand
Device Aided Medical Therapies
30 Minutes
Foundational / Beginner
CME Credits:0.501035 <p>This module will provide significant insights and practical tips on how to select good candidates for Subcutaneous Foslevodopa/Foscarbidopa infusion therapy, as well as its initial and long-term therapy and avoid or treat the device-related complications. </p> Infusion therapy, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Therapies-Pharmacological Justyna Sarna, MD, PhD 30 0.50 https://education.movementdisorders.org/Detail/1035/Essentials-of-Device-Assisted-Therapies-in-Parkinson's-Disease:-Starting-and-managing-a-patient-on-Subcutaneous-Foslevodopa/Foscarbidopa- https://education.movementdisorders.org/Upload/ActivityImages/7375321.jpg 2025-09-18T00:00:00 2028-09-18T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 0.50 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/DAT%20Module%207%20-%20Disclosures_12092025030419.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>FACULTY</strong></p><p>Justyna Sarna, MD, PhD - University of Calgary Calgary, AB, Canada</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity learners will be able to:</p><p>1. Understand the process for determining candidates for Foslevodopa/foscarbidopa therapy </p><p>2. Explore infusion strategy and titration </p><p>3. Manage infusion dosages of patients</p><p>4. Learn how to prevent and treat the common topical complications</p><p><br></p><p><strong>ABOUT THE ESSENTIALS OF DEVICE ASSISTED THERAPIES SERIES</strong></p><p>The MDS Essentials of Device-Assisted Therapies in Parkinson's Disease Series is an online education program designed to focus on the main practical issues involved in therapeutic treatments of Parkinson's Disease.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This course is intended for students, residents, neurologists, neurosurgeons, specialist nurses, and other health professionals.</p><p><br></p><p><strong>HOW TO TRANSLATE THIS MODULE</strong></p><p>For step-by-step guidance on how to translate this module using the Google Chrome web browser, please watch the video below:</p><p><br></p><p><span class="fr-video fr-dvb fr-draggable" contenteditable="false" draggable="false"> <video class="fr-draggable fr-fvc fr-dvi" controls="" height="300" width="533"><source src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/How To Translate - DAMT_15092025053301.mp4" type="video/mp4"> Your browser does not support HTML5 video.</video> </span></p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher)</p><p>3. Activity is best viewed on Mozilla Firefox or Google Chrome.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Essentials-of-Device-Assisted-Therapies-in-Parkinsons-Disease-Starting-and-managing-a-patient-on-Subcutaneous-FoslevodopaFoscarbidopa.htm Essentials of Device-Assisted Therapies in Parkinson's Disease: Starting and managing a patient on Subcutaneous Foslevodopa/Foscarbidopa 2025-09-18T12:01:05.863 0 0 Foundational / Beginner Clinician Fellow Industry Resident Student Device Aided Medical Therapies CME English On-Demand USA
Essentials of Device-Assisted Therapies in Parkinson's Disease: Starting and managing a patient on Subcutaneous Apomorphine
On Demand
Device Aided Medical Therapies
30 Minutes
Foundational / Beginner
CME Credits:0.501034 <p>This module provides a comprehensive, step-by-step guide for physicians on initiating and managing subcutaneous apomorphine therapy using both pen and pump delivery systems. Key topics include dosing, titration, management of common side effects, and patient and caregiver education. </p> Infusion therapy, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Therapies-Pharmacological Onanong Phokaewvarangkul, MD, PhD 30 0.50 https://education.movementdisorders.org/Detail/1034/Essentials-of-Device-Assisted-Therapies-in-Parkinson's-Disease:-Starting-and-managing-a-patient-on-Subcutaneous-Apomorphine-- https://education.movementdisorders.org/Upload/ActivityImages/6551914.jpg 2025-09-18T00:00:00 2028-09-18T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 0.5 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/DAT%20Module%206%20-%20Disclosures_12092025032947.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>FACULTY</strong></p><p>Onanong Phokaewvarangkul, MD, PhD - Chulalongkorn University Bangkok, Thailand </p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity learners will be able to:</p><p>1. Understand the clinical indications and patient selection criteria for initiating subcutaneous apomorphine therapy using pen and pump devices. </p><p>2. Apply appropriate dosing and titration protocols, including test dosing procedures. </p><p>3. Prevent, recognize and manage common adverse effects associated with subcutaneous apomorphine therapy to ensure patient safety and treatment adherence.</p><p><br></p><p><strong>ABOUT THE ESSENTIALS OF DEVICE ASSISTED THERAPIES SERIES</strong></p><p>The MDS Essentials of Device-Assisted Therapies in Parkinson's Disease Series is an online education program designed to focus on the main practical issues involved in therapeutic treatments of Parkinson's Disease.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This course is intended for students, residents, neurologists, neurosurgeons, specialist nurses, and other health professionals.</p><p><br></p><p><strong>HOW TO TRANSLATE THIS MODULE</strong></p><p>For step-by-step guidance on how to translate this module using the Google Chrome web browser, please watch the video below:</p><p><br></p><p><span class="fr-video fr-dvb fr-draggable" contenteditable="false" draggable="false"> <video class="fr-draggable fr-fvc fr-dvi" controls="" height="300" width="533"><source src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/How To Translate - DAMT_15092025053301.mp4" type="video/mp4"> Your browser does not support HTML5 video.</video> </span></p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher)</p><p>3. Activity is best viewed on Mozilla Firefox or Google Chrome.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Essentials-of-Device-Assisted-Therapies-in-Parkinsons-Disease-Starting-and-managing-a-patient-on-Subcutaneous-Apomorphine.htm Essentials of Device-Assisted Therapies in Parkinson's Disease: Starting and managing a patient on Subcutaneous Apomorphine 2025-09-18T12:01:05.067 0 0 Foundational / Beginner Clinician Fellow Industry Resident Student Device Aided Medical Therapies CME English On-Demand USA
Essentials of Device-Assisted Therapies in Parkinson's Disease: Brain Ablations: Rationale, mechanism of action, current evidence, indications, patient and target selection, and adverse effects
On Demand
Device Aided Medical Therapies
30 Minutes
Foundational / Beginner
CME Credits:0.501033 <p>This module will explore the rationale and mechanisms of action behind brain ablative therapies, including MRgFUS ,Gamma Knife Surgery (GKS) and MRI Guided Focused Ultrasound. Patient selection, current indications, potential adverse effects, long-term follow-up, and management strategies will also be discussed.</p> Focused Ultrasound, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Therapies-Surgical Raúl Martínez Fernández, MD, PhD 30 0.50 https://education.movementdisorders.org/Detail/1033/Essentials-of-Device-Assisted-Therapies-in-Parkinson's-Disease:-Brain-Ablations:-Rationale,-mechanism-of-action,-current-evidence,-indications,-patient-and-target-selection,-and-adverse-effects- https://education.movementdisorders.org/Upload/ActivityImages/5400618.jpg 2025-09-18T00:00:00 2028-09-18T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 0.5 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/DAT%20Module%205%20-%20Disclosures_12092025030058.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>FACULTY</strong></p><p>Raúl Martínez Fernández, MD, PhD - HM CINAC-Hospital Puerta Del Sur-CEU San Pablo, Madrid, Spain</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity learners will be able to:</p><p>1. Demonstrate an understanding of the rationale and mechanisms of action underlying brain ablation therapies. </p><p>2. Identify potential brain targets for MRgFUS-based ablation therapies. </p><p>3. Describe the types of brain ablative therapies, their indications, patient selection criteria, and potential adverse effects.</p><p><br></p><p><strong>ABOUT THE ESSENTIALS OF DEVICE ASSISTED THERAPIES IN PARKINSON'S DISEASE SERIES</strong></p><p>The MDS Essentials of Device-Assisted Therapies in Parkinson's Disease Series is an online education program designed to focus on the main practical issues involved in therapeutic treatments of Parkinson's Disease.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This course is intended for students, residents, neurologists, neurosurgeons, specialist nurses, and other health professionals.</p><p><br></p><p><strong>HOW TO TRANSLATE THIS MODULE</strong></p><p>For step-by-step guidance on how to translate this module using the Google Chrome web browser, please watch the video below:</p><p><br></p><p><span class="fr-video fr-dvb fr-draggable" contenteditable="false" draggable="false"> <video class="fr-draggable fr-fvc fr-dvi" controls="" height="300" width="533"><source src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/How To Translate - DAMT_15092025053301.mp4" type="video/mp4"> Your browser does not support HTML5 video.</video> </span></p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher)</p><p>3. Activity is best viewed on Mozilla Firefox or Google Chrome.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Essentials-of-Device-Assisted-Therapies-in-Parkinsons-Disease-Brain-Ablations-Rationale-mechanism-of-action-current-evidence-indications-patient-and-target-selection-and-adverse-effects.htm Essentials of Device-Assisted Therapies in Parkinson's Disease: Brain Ablations: Rationale, mechanism of action, current evidence, indications, patient and target selection, and adverse effects 2025-09-18T12:01:04.363 0 0 Foundational / Beginner Clinician Fellow Industry Resident Student Device Aided Medical Therapies CME English On-Demand USA